Cohort of patients with prosthetic joint infections
Official title: Prospective Cohort of Patients With Prosthetic Joint Infection
Run by Groupe Hospitalier Diaconesses Croix Saint-Simon · NCT02801253 · Data updated 2026-11-12
This study is tracking adults with prosthetic joint infections to see how different treatments affect their recovery and long-term health over two years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Groupe Hospitalier Diaconesses Croix Saint-Simon Academic / other |
| Locations | 1 site (Paris, Île-de-France Region) |
| Status | Recruiting |
| Started | September 11, 2015 |
| Main results expected | September 2025 |
| Study ends | September 2029 |
| Registry record updated | March 29, 2022 |
| Trial ID | NCT02801253 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old with hip, knee, or shoulder joint prostheses diagnosed with prosthetic joint infections.
✕Probably not a fit
Patients without a confirmed diagnosis of prosthetic joint infection or those under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational cohort study aims to manage and monitor patients with prosthetic joint infections (PJI) at a French referral center. It includes patients over 18 years old who have undergone various treatment strategies for PJI, such as debridement-synovectomy or exchange arthroplasty, and those receiving prolonged suppressive antibiotic therapy. The study will follow participants for at least two years to assess outcomes like reinfection rates, joint revisions, and mortality related to PJI. The study spans a total duration of 10 years, with a recruitment period of 4 years and a maximum data collection period of 6 years.
Why it matters
Potential benefit: If successful, this study could improve the management and treatment strategies for patients suffering from prosthetic joint infections.
How similar studies have gone: While there is a lack of large prospective studies in this area, the approach of long-term follow-up in managing PJI is promising and could provide valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient aged over 18 years old with hip, knee and or shoulder joint prosthesis who consented to participate in the study with: * According to musculoskeletal infection society definition: PJI is present when one of the major criteria exists or four out of six minor criteria. Major Criteria: * Two positive periprosthetic cultures with phenotypically identical organisms, OR * A sinus tract communicating with the joint, OR Minor Criteria: * Elevated serum C-reactive protein (CRP) AND erythrocyte sedimentation rate (ESR) * Elevated synovial fluid white blood cell (WBC) * Elevated synovial fluid polymorphonuclear neutrophil percentage (PMN%) * The presence of pus in the joint without known cause * Positive histological analysis of periprosthetic tissue * A single positive culture Or a PJI which meets the following three criteria: * Medical story suggesting prosthetic joint infection. * The presence of pain either with or without swelling for more than 3 months unrelated to a mechanical cause. * Germ identification in a single sample of fluid aspiration or tissue culture. * Or microbial growth in prosthesis sonication fluid culture greater than 50CFU/ml. Exclusion Criteria: * Patient who does not meet eligibility criteria. * Patient lawfully deprived of his liberty. * Patient not insured under social security scheme.
Where it's running
-
Groupe Hospitalier Diaconesses Croix Saint Simon
Paris, Île-de-France Region, France Recruiting
Study contacts
- Principal investigator: VALERIE ZELLER, Doctorate — Groupe Hospitalier Diaconesses Croix Saint-Simon
- Study coordinator: YOUNES KERROUMI, Doctorate
- Email: ykerroumi@hopital-dcss.org
- Phone: (+33) 1 64 44 33 84
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How knee and hip joint replacements are doing over time
This observational study follows adults who have knee or hip replacements to see how their outcomes look over time after the surgery.
-
Population pharmacokinetics of rifampicin in staphylococcal osteoarticular infections
This study tests how rifampicin behaves in the body of adults with staphylococcal osteoarticular infections when given with levofloxacin or ciprofloxacin, to see how drug exposure relates to tolerance and outcomes.
-
Reducing bacterial contamination during primary shoulder replacement
This trial tests whether putting Prontosan antimicrobial gel on the dermal layer after the skin is cut can lower Cutibacterium acnes growth in men having primary shoulder replacement.
-
Methylene blue dye to measure how much irrigation clears contamination during knee replacement procedures
We will test whether putting methylene blue dye into the knee during replacement or DAIR procedures can show how much irrigation is needed to wash out contaminants.
-
PLG0206 irrigation to prevent repeat knee replacement infections after DAIR
This will test if washing the knee with PLG0206 during a DAIR procedure can lower the chance that a prosthetic knee infection comes back in adults who had a knee replacement.
-
Prosthetic joint infection patterns in critically ill patients who died
This project looks at health records of adults who died in intensive care with a hip, knee, or shoulder prosthetic joint infection from 2018–2022 to see common care paths and outcomes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.